SYSTEMATIC LITERATURE REVIEW FOR TREATMENT OUTCOMES (INCLUDING IMMUNO-ONCOLOGY TREATMENT) AMONG PATIENTS WITH STAGE 3 UNRESECTABLE NON-SMALL CELL LUNG CANCER (NSCLC)

被引：1
|
作者：
Zhou, Z. [1 ]
Song, J. [2 ]
Ouwens, M. J. [3 ]
Huhn, M. [3 ]
Jiang, H. [4 ]
Zhang, Y. [4 ]
Dalevi, D. [3 ]
机构：
[1] Anal Grp Inc, Boston, MA USA
[2] Anal Grp Inc, Los Angeles, CA USA
[3] Astrazeneca, Molndal, Sweden
[4] Astrazeneca, Gaithersburg, MD USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.110
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN28
引用
收藏
页码：A416 / A416
页数：1
相关论文
共 50 条
  • [31] SYSTEMATIC LITERATURE REVIEW OF TREATMENTS FOR PATIENTS WITH UNTREATED ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC)
    Song, J.
    Huang, M.
    Kelkar, S. S.
    Zhou, Z.
    Zhang, Y.
    [J]. VALUE IN HEALTH, 2018, 21 : S15 - S16
  • [32] Advances in Non-Small Cell Lung Cancer (NSCLC) Treatment-A Paradigm Shift in Oncology
    Ali, Azhar
    [J]. PHARMACEUTICALS, 2024, 17 (02)
  • [33] Outcomes of radical treatment of early stage non-small cell lung cancer
    Yap, Carissa
    Hakendorf, Paul
    Woodman, Richard
    Lance, David
    Leung, John
    Bowdenand, Jeffrey
    Rose, Anand
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [34] OUTCOMES OF RADICAL TREATMENT OF EARLY STAGE NON-SMALL CELL LUNG CANCER
    Yap, C.
    Hakendorf, P.
    Woodman, R.
    Lance, D.
    Leung, J.
    D'Costa, J.
    Bowden, J.
    Rose, A.
    [J]. RESPIROLOGY, 2015, 20 : 38 - 38
  • [35] Non-Small Cell Lung Cancer (NSCLC) - treatment research and treatment reality in oncology practices (adjuvant therapy)
    Wilhelm, S.
    Hutzschenreuter, U.
    Innig, G.
    Goettel, R.
    Tessen, H. -W
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 91 - 92
  • [36] Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-Introduction
    Socinski, Mark A.
    [J]. SEMINARS IN ONCOLOGY, 2015, 42 (05) : S1 - S2
  • [37] PROFILES OF NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH IMMUNO-ONCOLOGY THERAPIES IN THE UNITED STATES AND WESTERN EUROPE
    Shah-Manek, B.
    Karki, C.
    Whitmire, S. M.
    Ilacqua, J.
    Wriede, V
    [J]. VALUE IN HEALTH, 2018, 21 : S40 - S40
  • [38] RISK FACTORS OF TREATMENT DELAY AMONG NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS IN LOUISIANA
    Zhang, Y.
    Hsieh, M. C.
    Nauman, E.
    Callison, K.
    Tackett, S.
    Shi, L.
    [J]. VALUE IN HEALTH, 2021, 24 : S56 - S57
  • [39] Treatment Patterns and Clinical Practices of Advanced (Stage IV) Non-Small Cell Lung Cancer (NSCLC) in Europe - A Structured Literature Review
    Brodowicz, Thomas
    Niepel, Daniela
    Booth, Emma
    Hernandez, Rohini K.
    Braileanu, George
    Cawkwell, Marie
    Amelio, Justyna
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S676 - S676
  • [40] Demographics, clinical characteristics and treatment sequencing in stage 3 Unresectable non-small cell lung cancer patients: A Cancerlinq cohort
    Klein, Alyssa B.
    Herr, Iksha
    MacLachlan, Sharon
    Potter, Danielle
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 136 - 137
12345